The BalancedInvestor Club

NMTC Market Analysis

Overview

Fundamentals

P/E ratio—
EPS (TTM)$-1.080.0% YoY
Profit margin-58.3%HEALTHCARE
Market cap$36.8MMicro cap

Wall Street coverage

$11.87median target· current $7.02 (+69.1%)3 analysts

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

Valuation

Forward P/E
—
PEG ratio
—
P/B
5.77
P/S (TTM)
3.14
EV/EBITDA
-2.10

Profitability & growth

ROE (TTM)
-146.3%
Operating margin
-59.0%
Revenue growth YoY
-11.7%
Dividend yield
—
Beta
0.58
Last earnings
Feb 17, 2026 · Estimate $-0.04 · Reported $-0.03
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

Page 1 of 3 · 50 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About Neuroone Medical Technologies Corp

NeuroOne Medical Technologies Corporation is a medical technology company. The company is headquartered in Eden Prairie, Minnesota.

Classification

Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
Country
USA
Currency
USD

Company profile

HQ
7599 ANAGRAM DRIVE, EDEN PRAIRIE, MN
Fiscal year end
September
Latest quarter
Dec 31, 2025
Market cap$36.8M
Shares outstanding$8.4M
52W high$6.96
52W low$3.28

Educational content · Not investment advice or recommendations

We're educators, not advisors. Your decisions are your own. Disclaimer